Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Cathy Eng, James C. Yao et al.|The Lancet|2023Cited by 319
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myelomaWilliam C. Pilcher, Shaji Kumar, Lijun Yao et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 14
Determinants of gastric cancer immune escape identified from non-coding immune-landscape quantitative trait lociChristos Miliotis, Ioannis S. Vlachos, Yuling Ma et al.|Nature Communications|2024Cited by 5